To include your compound in the COVID-19 Resource Center, submit it here.

CFDA planning to double reviewers

China FDA's Chief Scientist Ruyi He said at the WuXi Global Forum in San Francisco on Tuesday that the agency plans to double the number of its reviewers

Read the full 286 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE